The pneumonia is caused by tiny Mycoplasma pneumoniae bacteria and cases are spiking this year, particularly among ...

If you're not feeling well, it may be difficult to determine whether you have the flu, COVID or allergies. Here's how to tell ...

Student Health reports higher cases of respiratory infections this season, including a few cases of pertussis — also known as ...

The 'tripledemic' is affecting the United Kingdom, with the English anticipating a rise in cases during the winter. Attention ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...

Study explores the clinical manifestations, risk factors, and 90-day mortality outcomes in adults hospitalized with RSV or ...

As the leaves change and the air turns crisp, fall officially marks the onset of “sick season.”With the arrival of cooler ...

Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...

Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...

Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.

The North Carolina Department of Health and Human Services is reporting the first flu-related death of the 2024-25 flu season. An adult in the Charlotte metropolitan area died due to complications of ...

Flu season is back in Oklahoma, and health officials are urging residents to take precautions as the weather cools and people spend more time indoors.